Introduction:
The article discusses how new technologies, specifically Quantitative Trait Loci (QTL) technology in combination with complex systems science, can potentially address the escalating cost of healthcare. QTL technology is currently used in the biomanufacturing industry to create optimum strains of yeast, but it can also be used to understand biological function and develop more effective treatments for degenerative and metabolic diseases.
- Lifestyle choices and their impact on healthy bodily function and disease are highly complex and manifest in biologically chaotic ways.
- Human genes don’t change, but mutations and damage can affect the intricate systems that drive bodily function.
- Most human diseases are not predetermined by genetics, but genes can make individuals vulnerable to specific malfunctions. Interactions with the environment play a role in altering bodily systems.
- Lifestyles can make treating or reversing degenerative and metabolic diseases more difficult and complex.
- Understanding complex systems and their interactions with the environment is crucial for developing solutions to diseases and addressing the symptoms of aging.
Conclusion:
The use of breeding, screening, genomic analysis, and QTL technology in complex systems science provides a toolkit to tackle the challenges posed by escalating healthcare costs. By unraveling biological complexity and identifying intervention points, these technologies can potentially lead to more effective treatments and solutions for degenerative and metabolic diseases.
